This concept is based on studies that have documented the activity of nNOS and eNOS in the prefrontal cortex [222], the total number of NOS-immunoreactive paraventricular neurons [3], as well as the level of NO and its metabolites in plasma [239,240] in patients with depression. This evidence concerns the gene NOS1 and depressive disorder.